This study is for the treatment of localized, muscle-invasive bladder cancer
This study is for the treatment of localized, muscle-invasive bladder cancer.
Study phase: II
Primary disease category: Cancer
Sponsor: Southwest Oncology Group (SWOG) / National Cancer Institute (NCI)
Protocol number: S1314
Projected enrollment dates: December 2014 to December 2018
Official study title: A RANDOMIZED PHASE II STUDY OF CO-EXPRESSION EXTRAPOLATION (COXEN) WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED, MUSCLE-INVASIVE BLADDER CANCER (S1314)